{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:27:32Z","timestamp":1791178052897,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00431-009-1039-4","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T06:17:09Z","timestamp":1251181029000},"page":"7-13","source":"Crossref","is-referenced-by-count":98,"title":["Clinical practice"],"prefix":"10.1007","volume":"169","author":[{"given":"Johanna","family":"Scheiring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar Bernd","family":"Zimmerhackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"issue":"8","key":"1039_CR1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1086\/587664","volume":"46","author":"CK Ahn","year":"2008","unstructured":"Ahn CK, Klein E, Tarr PI (2008) Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome. Clin Infect Dis 46(8):1197\u20131199","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1039_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","volume":"24","author":"G Ariceta","year":"2009","unstructured":"Ariceta G, Besbas N, Johnson S et al (2009) The European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24(4):687\u2013696","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"1039_CR3","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.168.12.6298","volume":"168","author":"ML Barilla-LaBarca","year":"2002","unstructured":"Barilla-LaBarca ML, Liszewski MK, Lambris JD et al (2002) Role of membrane Cofactor protein (CD46) in regulation of C4b and C3b deposits on cells. J Immunol 168(12):6298\u20136304","journal-title":"J Immunol"},{"key":"1039_CR4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199508103330608","volume":"333","author":"TG Boyce","year":"1995","unstructured":"Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic uremic syndrome. N Engl J Med 333:364","journal-title":"N Engl J Med"},{"key":"1039_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.110.2.371","volume":"110","author":"J Brandt","year":"2002","unstructured":"Brandt J, Wong C, Mihm S et al (2002) Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 110:371\u2013375","journal-title":"Pediatrics"},{"key":"1039_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1542\/peds.101.4.699","volume":"101","author":"GR Cabrera","year":"1998","unstructured":"Cabrera GR, Fortenberry JD, Warshaw BL et al (1998) Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection. Pediatrics 101:699\u2013703","journal-title":"Pediatrics"},{"key":"1039_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-003-1382-z","volume":"19","author":"JB Cochran","year":"2004","unstructured":"Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW (2004) Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome. Pediatr Nephrol 19:317\u2013321","journal-title":"Pediatr Nephrol"},{"key":"1039_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","volume":"151","author":"RS Cordoba de","year":"2008","unstructured":"de Cordoba RS, de Goicoechea JE (2008) Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 151:1\u201313","journal-title":"Clin Exp Immunol"},{"key":"1039_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-005-0003-2","volume":"27","author":"MA Dragon-Durey","year":"2005","unstructured":"Dragon-Durey MA, Fremeaux-Bacchi V (2005) Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27:359\u2013374","journal-title":"Springer Semin Immunopathol"},{"key":"1039_CR10","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","volume":"41","author":"V Fremeaux-Bacchi","year":"2004","unstructured":"Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J et al (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:e84","journal-title":"J Med Genet"},{"issue":"13","key":"1039_CR11","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fr\u00e9meaux-Bacchi","year":"2008","unstructured":"Fr\u00e9meaux-Bacchi V, Miller EC, Liszewski MK et al (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112(13):4948\u20134952","journal-title":"Blood"},{"key":"1039_CR12","first-page":"905","volume":"85","author":"C Gasser","year":"1955","unstructured":"Gasser C, Gautier E, Steck A et al (1955) H\u00e4molytisch-ur\u00e4mische Syndrome: bilaterale Nierenrindennekrose bei akut erworbenen h\u00e4molytischen An\u00e4mien. Schweiz Med Wochenschr 85:905\u2013909","journal-title":"Schweiz Med Wochenschr"},{"key":"1039_CR13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00467-003-1192-3","volume":"18","author":"A Gerber","year":"2003","unstructured":"Gerber A, Kirchhoff-Modapour AH, Obieglo S et al (2003) Successful (?) therapy of hemolytic uremic syndrome with factor H abnormality. Pediatr Nephrol 18:952\u2013955","journal-title":"Pediatr Nephrol"},{"key":"1039_CR14","first-page":"315","volume-title":"Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","author":"R Habib","year":"1992","unstructured":"Habib R (1992) Pathology of the hemolytic uremic syndrome. In: Kaplan B, Trompeter R, Moake J (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Marcel dekker, New York, pp 315\u2013353"},{"key":"1039_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","volume":"151","author":"MA Karmali","year":"1985","unstructured":"Karmali MA, Petric M, Lim C et al (1985) The association between idiopathic haemolytic uraemic syndrome and infection by Verotoxin producing E. coli. J Infect Dis 151:775\u2013782","journal-title":"J Infect Dis"},{"key":"1039_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldl004","volume":"77\u201378","author":"D Kavanagh","year":"2006","unstructured":"Kavanagh D, Goodship THJ, Richars A (2006) Atypical haemolytic uraemic syndrome. Br Med Bull 77\u201378:5\u201322","journal-title":"Br Med Bull"},{"key":"1039_CR17","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","volume":"16","author":"D Kavanagh","year":"2005","unstructured":"Kavanagh D, Kemp EJ, Mayland E et al (2005) Mutations in complement factor I predispose to development of atypical haemolytic uraemic syndrome. J Am Soc Nephrol 16:2150\u20132155","journal-title":"J Am Soc Nephrol"},{"key":"1039_CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1011921122595","volume":"3","author":"J Liu","year":"2001","unstructured":"Liu J, Hutzler M, Li C, Pechet I (2001) Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). The new thinking. J Thromb Thrombolysis 3:261\u2013272","journal-title":"J Thromb Thrombolysis"},{"key":"1039_CR19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00467-003-1289-8","volume":"18","author":"C Loirat","year":"2003","unstructured":"Loirat C, Niaudet P (2003) The risk of recurrence after haemolytic uraemic syndrome after renal transplantation in children. Pediatr Nephrol 18:1095\u20131101","journal-title":"Pediatr Nephrol"},{"key":"1039_CR20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(98)70223-9","volume":"133","author":"NE Moghal","year":"1998","unstructured":"Moghal NE, Ferreira MA, Howie AH et al (1998) The late histologic findings in diarrhoea associated haemolytic uraemic syndrome. J Pediatr 133:220\u2013223","journal-title":"J Pediatr"},{"key":"1039_CR21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/IAI.70.2.612-619.2002","volume":"70","author":"J Mukherjee","year":"2002","unstructured":"Mukherjee J, Chios K, Fishwild D et al (2002) Human Stx2 specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun 70:612\u2013619","journal-title":"Infect Immun"},{"key":"1039_CR22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s004670100564","volume":"16","author":"S Nathanson","year":"2001","unstructured":"Nathanson S, Deschenes G (2001) Prognosis of Streptococcus pneumoniae induced hemolytic uremic syndrome. Pediatr Nephrol 16:362\u2013365","journal-title":"Pediatr Nephrol"},{"key":"1039_CR23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G (2005) Haemolytic uraemic syndrome. J Am Soc Nephrol 16:1035\u20131050","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1039_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03558.x","volume":"151","author":"M Noris","year":"2008","unstructured":"Noris M, Remuzzi G (2008) Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin Exp Immunol 151(2):199\u2013209 (review)","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1039_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","volume":"360","author":"J Nuernberger","year":"2009","unstructured":"Nuernberger J, Witzke O, Saez AO et al (2009) Eculizumab for atypical hemolytic uremic syndrome. N Engl J Med 360(5):542\u2013544","journal-title":"N Engl J Med"},{"issue":"1","key":"1039_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/14787210.6.1.101","volume":"6","author":"D Orth","year":"2008","unstructured":"Orth D, Grif K, Zimmerhackl LB, W\u00fcrzner R (2008) Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans. Expert Rev Anti Infect Ther 6(1):101\u2013108, Review","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1039_CR27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.105.2.462","volume":"105","author":"F Proulz","year":"2000","unstructured":"Proulz F, Liet JM, Michele D et al (2000) Hemolytic uremic syndrome associated with invasive Streptococcus infection. Pediatrics 105:462\u2013463","journal-title":"Pediatrics"},{"issue":"2","key":"1039_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2006-939768","volume":"32","author":"F Pr\u00fcfer","year":"2006","unstructured":"Pr\u00fcfer F, Scheiring J, Sautter S et al (2006) Terminal complement complex (C5b-9) in children with recurrent haemolytic uraemic syndrome. Semin Thromb Hemost 32(2):121\u2013127","journal-title":"Semin Thromb Hemost"},{"issue":"22","key":"1039_CR29","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards A, Kemp EJ, Liszewski MK et al (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100(22):12966\u201312971","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2001","key":"1039_CR30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome and thrombocytopenic purpura. Kidney Int 60(2001):831\u2013846","journal-title":"Kidney Int"},{"issue":"6","key":"1039_CR31","first-page":"300","volume":"11","author":"P Ruggenenti","year":"1998","unstructured":"Ruggenenti P, Remuzzi G (1998) Pathophysiology and management of thrombotic microangiopathies. J Nephrol 11(6):300\u2013310","journal-title":"J Nephrol"},{"key":"1039_CR32","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome. Pediatr Nephrol 23:1749\u20131760","journal-title":"Pediatr Nephrol"},{"key":"1039_CR33","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1128\/IAI.73.8.4607-4613.2005","volume":"73","author":"AS Sheoran","year":"2005","unstructured":"Sheoran AS, Chapman-Bonofiglio S, Harvey BR et al (2005) Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun 73:4607\u20134613","journal-title":"Infect Immun"},{"key":"1039_CR34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1594.1995.tb02370.x","volume":"19","author":"J Slavicek","year":"1995","unstructured":"Slavicek J, Puretic Z, Novak M, Sarnavka V (1995) The role of plasma exchange in the treatment of severe forms of hemolytic uremic syndrome in childhood. Artif Organs 19:506","journal-title":"Artif Organs"},{"issue":"9464","key":"1039_CR35","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365(9464):1073\u20131086","journal-title":"Lancet"},{"issue":"6","key":"1039_CR36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00467-004-1451-y","volume":"19","author":"M Dyck Van","year":"2004","unstructured":"Van Dyck M, Proesmans W (2004) Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Pediatr Nephrol 19(6):688\u2013690","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"1039_CR37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s150100050040","volume":"27","author":"HM Verweyen","year":"1999","unstructured":"Verweyen HM, Karch H, Allerberger F, Zimmerhackl LB (1999) Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic uremic syndrome: a prospective study in Germany and Austria. Infection 27(6):341\u2013347","journal-title":"Infection"},{"key":"1039_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004670050018","volume":"14","author":"HM Verweyen","year":"2000","unstructured":"Verweyen HM, Karch H, Brandis M, Zimmerhackl LB (2000) Enterohemorrhagic Escherichia coli infection: following transmission routes. Pediatr Nephrol 14:73\u201383","journal-title":"Pediatr Nephrol"},{"issue":"26","key":"1039_CR39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422611","volume":"342","author":"LB Zimmerhackl","year":"2000","unstructured":"Zimmerhackl LB (2000) E. coli, antibiotics and the hemolytic uremic syndrome. N Engl J Med 342(26):1930\u20131936","journal-title":"N Engl J Med"},{"issue":"2","key":"1039_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2006-939767","volume":"32","author":"LB Zimmerhackl","year":"2006","unstructured":"Zimmerhackl LB, Besbas N, Jungraithmayr T et al (2006) European Study Group for haemolytic uraemic syndromes and related disorders: epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost 32(2):113\u2013120","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"1039_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00467-006-0210-7","volume":"22","author":"LB Zimmerhackl","year":"2007","unstructured":"Zimmerhackl LB, Scheiring J, Pruefer F et al (2007) Renal transplantation in HUS patients with disorders of complement regulation. Pediatr Nephrol 22(1):10\u201316","journal-title":"Pediatr Nephrol"},{"key":"1039_CR42","unstructured":"Zimmerhackl LB, Verweyen HM, Gerber A, et al. (2002) Das h\u00e4molytisch ur\u00e4mische Syndrom. Deutsches \u00c4rzteblatt, Ausgabe 4 vom 25.01.2002, Seite A-196\/B-157\/C-153"},{"key":"1039_CR43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4906(01)01972-X","volume":"22","author":"P Zipfel","year":"2001","unstructured":"Zipfel P (2001) Haemolytic uraemic syndrome: how do factor H mutants mediate endothelial damage? Trends Immunol 22:345\u2013348","journal-title":"Trends Immunol"},{"key":"1039_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2005.06.015","volume":"43","author":"PF Zipfel","year":"2006","unstructured":"Zipfel PF, Heinen S, Jozsi M, Skerka C (2006) Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 43:97\u2013106","journal-title":"Mol Immunol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-009-1039-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-009-1039-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-009-1039-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:26:07Z","timestamp":1559082367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-009-1039-4"}},"subtitle":["Today\u2019s understanding of the haemolytic uraemic syndrome"],"short-title":[],"issued":{"date-parts":[[2009,8,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1007\/s00431-009-1039-4","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,26]]}}}